Back
Adverse Drug Reactions in Management of Multi Drug Resistant Tuberculosis, in Tertiary Chest Institute
J. S. Akshata, Anushree Chakrabarthy, R. Swapna, Shashidhar Buggi, M. Somashekar
J. Tuberc. Res. Vol.3 No.2, April 16, 2015  DOI: 10.4236/jtr.2015.32004
       (PDF  425K)     HTML      XML
Unbiased Multirresistance Prevalences in Real Testing Practices? An Intuitive Correcting Approach Applied to Tuberculosis in Portugal
Cristiana Areias, Teodoro Briz, Carla Nunes
J. Tuberc. Res. Vol.2 No.2, June 11, 2014  DOI: 10.4236/jtr.2014.22010
       (PDF  1817K)     HTML      XML
Low Detection Rate of Multidrug-Resistant and Rifampicin-Resistant Tuberculosis in the Democratic Republic of Congo: Trend Analysis 2013-2017
Innocent Kashongwe Murhula, Fina Mawete, Lay Ofali, Michel Kaswa, Francois Lepira Bompeka, Jean Marie Kayembe Ntumba, Zacharie Kashongwe Munogolo
J. Tuberc. Res. Vol.7 No.4, November 08, 2019  DOI: 10.4236/jtr.2019.74020
       (PDF  514K)     HTML      XML
Pre-Extensively Drug Resistant Tuberculosis (Pre-XDR-TB) among Pulmonary Multidrug Resistant Tuberculosis (MDR-TB) Patients in Bangladesh
Tamanna Tasnim, Shirin Tarafder, Fatema Mohammad Alam, Humayun Sattar, S. M. Mostofa Kamal
J. Tuberc. Res. Vol.6 No.3, July 24, 2018  DOI: 10.4236/jtr.2018.63018
       (PDF  303K)     HTML      XML
Factors Associated with Mortality among Multidrug Resistant Tuberculosis MDR/RR-TB Patients in Democratic Republic of Congo
Murhula Innocent Kashongwe, Leopoldine Mbulula, Pierre Umba, Francois Bompeka Lepira, Michel Kaswa, Zacharie Munogolo Kashongwe
J. Tuberc. Res. Vol.5 No.4, December 15, 2017  DOI: 10.4236/jtr.2017.54029
       (PDF  1482K)     HTML      XML
 
 
Top